Multiple Sclerosis Clinical Trials

Showing 2181-2200 of 2,839 trials

Developing and Testing a Comprehensive MS Spasticity Management Program

NCT02170779

This is a study to determine the impact of education and specific lower extremity stretches for MS-related spasticity. The study will evaluate the acceptance and efficacy of education and stretching using a randomized controlled pilot trial.

Multiple SclerosisSpasticity

VA Office of Research and Development40 participantsStarted Oct 2015

Portland, Oregon, United States

UNKNOWNNA

Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer

NCT02725125

This single-arm, multicenter Phase 2 trial will treat the patients who have relapsed or refractory stomach cancer with an infusion of the patient's own T cells that have been genetically modified to express a chimeric antigen receptor(CAR) that will bind to tumor cells that express the EPCAM protein on the cell surface.The study will determine if these modified T cells help the body's immune system eliminate tumor cells.The trial will also study the safety of treatment with CAR-T, how long CAR-T cells stay in the patient's body and the impact of this treatment on survival.

Stomach Neoplasms

Sinobioway Cell Therapy Co., Ltd.19 participantsStarted Nov 2015

Hefei, Anhui, China

COMPLETEDPhase 4

Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients

NCT01968902

The purpose of this study is to determine if Xeomin® will prove effective for significantly improving lower extremity spasticity and will be well tolerated by the majority of MS patients.

Muscle SpasticityMultiple Sclerosis

Multiple Sclerosis Center of Northeastern New York27 participantsStarted Nov 2013

Latham, New York, United States

Developing and Testing a Comprehensive MS Spasticity Management Program

Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer

Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients

Related Searches

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms

Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

The Immediate Effect of Kinesio Tape on Hamstring Muscle Length in Female Students of University of Dammam

Japanese National Computed Tomographic (CT) Colonography Trial

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

The Pharmacokinetics and Safety of Onartuzumab (MetMAb) in Chinese Patients With Locally Advanced or Metastatic Solid Tumors

Middle Cerebral Artery Velocity and Oxygen Saturation of the Brain During Carotid Endarterectomy

Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations

Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer

Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents